you are here:

Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals

BSE Live

Nov 25, 16:00
466.40 -14.15 (-2.94%)
Volume
AVERAGE VOLUME
5-Day
92,461
10-Day
97,923
30-Day
116,156
175,148
  • Prev. Close

    480.55

  • Open Price

    483.15

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Nov 25, 15:59
466.30 -14.20 (-2.96%)
Volume
AVERAGE VOLUME
5-Day
1,803,272
10-Day
1,903,827
30-Day
2,759,239
2,611,985
  • Prev. Close

    480.50

  • Open Price

    484.00

  • Bid Price (Qty.)

    466.30 (620)

  • Offer Price (Qty.)

    0.00 (0)

Financials

2019 2018 2017 2016 2015
Half Yearly Results of Glenmark Pharma (in Rs. Cr.) Mar '20 Sep '19 Mar '19 Sep '18 Mar '18  
Net Sales/Income from operations 3,424.02 3,197.86 3,130.66 3,000.48 2,965.57  
Other Operating Income -- 90.76 88.66 85.07 258.72  
Total Income From Operations 3,424.02 3,288.61 3,219.32 3,085.55 3,224.29  
EXPENDITURE  
Consumption of Raw Materials 1,165.02 1,086.96 791.44 794.42 1,053.72  
Purchase of Traded Goods 175.76 189.49 138.51 162.79 152.46  
Increase/Decrease in Stocks 38.37 10.40 314.40 157.41 4.28  
Power & Fuel -- -- -- -- --  
Employees Cost 506.52 565.81 456.31 513.67 487.73  
Depreciation 73.05 65.49 52.05 54.23 59.37  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 923.30 746.78 900.55 747.90 928.99  
P/L Before Other 542.01 623.69 566.05 655.15 537.74  
Other Income 345.78 261.01 83.75 391.87 81.53  
P/L Before Int. 887.79 884.69 649.80 1,047.01 619.27  
Interest 123.15 133.24 107.79 116.02 97.72  
P/L Before Exceptional Items & Tax 764.64 751.45 542.01 930.99 521.55  
Exceptional Items 18.55 -- -- 345.19 --  
P/L Before Tax 783.19 751.45 542.01 1,276.17 521.55  
Tax 88.48 91.62 91.30 238.58 105.92  
P/L After Tax from Ordinary Activities 694.71 659.84 450.71 1,037.59 415.63  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- 26.45 107.36 --  
Net Profit/(Loss) For the Period 694.71 659.84 477.16 1,144.95 415.63  
Equity Share Capital 28.22 28.22 28.22 28.22 28.22  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 24.62 23.38 -- 40.58 --  
Diluted EPS -- 23.38 -- 40.58 --  
EPS After Extra Ordinary  
Basic EPS. 24.62 23.38 -- 40.58 --  
Diluted EPS. -- 23.38 -- 40.58 --  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group). -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company). -- -- -- -- --  
Source : Dion Global Solutions Limited